Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Humacyte (HUMA) EBT Margin (2025)

Humacyte has reported EBT Margin over the past 1 years, most recently at 7149.68% for Q4 2025.

  • Quarterly results put EBT Margin at 7149.68% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 5729.29% (changed N/A YoY), and the annual figure for FY2025 was 5729.29%, changed.
  • EBT Margin for Q4 2025 was 7149.68% at Humacyte, down from 3507.57% in the prior quarter.
  • Over the last five years, EBT Margin for HUMA hit a ceiling of 3507.57% in Q3 2025 and a floor of 10445.18% in Q2 2025.